Whitehawk Therapeutics appoints former Incyte executive Vijay Iyengar to board

Reuters2026/09/10 20:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Whitehawk Therapeutics appointed Vijay Iyengar to its board, effective Sept. 9, 2026.
Iyengar previously held senior leadership roles at Incyte, supporting five brand launches across eight indications and expansion into more than 20 countries.
He also held senior oncology leadership roles at Novartis, earlier serving as an engagement manager at McKinsey’s healthcare practice.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609101605PR_NEWS_USPR_____LA45157) on September 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Whitehawk Therapeutics appoints former Incyte executive Vijay Iyengar to board

You may also like

Crypto prices